SCHEMBL668374

SCHEMBL668374

COc1cc(CN2CCC(O)CC2)ccc1-c1cccc(Cl)c1

nearest known ligand 0.61

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 3/20 0.61
HTR7 P34969 5/20 0.54
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
ATM Q13315 1/20 0.49
BCHE P06276 1/20 0.48
ACHE P22303 1/20 0.48
USP2 O75604 1/20 0.47
LMNA P02545 1/20 0.47
THRB P10828 1/20 0.47
DRD2 P14416 1/20 0.47
DRD4 P21917 1/20 0.47
DRD3 P35462 1/20 0.47
KDM4E B2RXH2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL668624 0.87 ABCB1 (0.52) HTR7MEN1KMT2AATMBCHE
SCHEMBL669902 0.85 MEN1 (0.58) HTR7MEN1KMT2AATMKDM4E
SCHEMBL668404 0.84 MEN1 (0.47) PDE4BHTR7MEN1KMT2AATM
SCHEMBL668424 0.83 ALDH1A1 (0.48) PDE4BHTR7MEN1KMT2ADRD4
SCHEMBL667854 0.82 MEN1 (0.50) HTR7MEN1KMT2AATMDRD4
SCHEMBL669387 0.80 GRM2 (0.53) HTR7MEN1KMT2AATMBCHE
SCHEMBL8554437 0.79 SIGMAR1 (0.68) ATMDRD2DRD4DRD3KDM4E
SCHEMBL520969 0.75 KDM4E (0.55) HTR7MEN1KMT2AATMACHE
SCHEMBL7066532 0.75 RAB9A (0.52) MEN1KMT2ABCHEACHELMNA
SCHEMBL16144706 0.73 PDE4B (0.70) PDE4BHTR7KMT2ADRD2DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2606049-A2 2,5-METHANO-AND 2,5-ETHANO-TETRAHYDROBENZAZEPINE DERIVATIVES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN Albany Molecular Research, Inc. (US) 2013-06-26 EP disclosed
WO-2012024397-A2 2,5-METHANO-AND 2,5-ETHANO-TETRAHYDROBENZAZEPINE DERIVATIVES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ALBANY MOLECULAR RESEARCH, INC. (US) 2012-02-23 WO disclosed